logo-loader
viewFutura Medical PLC

Futura Medical's James Barder looking forward to headline data on lead drug by year-end

Futura Medical PLC (LON:FUM) chief executive James Barder caught up with Proactive London's Andrew Scott to talk through the firm's interim results.

He says the company’s team is speaking to key opinion leaders in the field of erectile dysfunction ahead of publishing headline data on lead erectile dysfunction drug MED 2005 later this year.

It's a fast-acting gel that eliminates some of the common side-effects of the current pill-based treatments.

Quick facts: Futura Medical PLC

Price: 12.2 GBX

AIM:FUM
Market: AIM
Market Cap: £29.97 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Futura Medical PLC named herein, including the promotion by the Company of Futura Medical PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Futura Medical kicks off process for its ED gel to be approved as medical device

Futura Medical PLC's (LON:FUM) Ken James tells Proactive London's Andrew Scott they've held positive initial discussions with EU regulators as it confirmed it will seek to have its erectile dysfunction (ED) gel approved as a medical device rather than a drug. The decision to develop the gel...

1 week, 6 days ago

2 min read